Oncorus

Oncorus is focused on realizing the full promise of IV-administered, self-amplifying RNA medicines to transform outcomes for cancer patients. We believe this modality has the potential to safely and effectively kill tumor cells and stimulate multiple arms of the immune system to better fight cancer.